Cargando…

Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3

The neurotensin (NT) receptor-3 (NTSR3), also called sortilin is a multifunctional protein localized at the intracellular and plasma membrane level. The extracellular domain of NTSR3 (sNTSR3) is released by shedding from several cell lines including colonic cancer cells. This soluble protein acts as...

Descripción completa

Detalles Bibliográficos
Autores principales: Massa, Fabienne, Devader, Christelle, Lacas-Gervais, Sandra, Béraud-Dufour, Sophie, Coppola, Thierry, Mazella, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162136/
https://www.ncbi.nlm.nih.gov/pubmed/25221642
_version_ 1782334651044462592
author Massa, Fabienne
Devader, Christelle
Lacas-Gervais, Sandra
Béraud-Dufour, Sophie
Coppola, Thierry
Mazella, Jean
author_facet Massa, Fabienne
Devader, Christelle
Lacas-Gervais, Sandra
Béraud-Dufour, Sophie
Coppola, Thierry
Mazella, Jean
author_sort Massa, Fabienne
collection PubMed
description The neurotensin (NT) receptor-3 (NTSR3), also called sortilin is a multifunctional protein localized at the intracellular and plasma membrane level. The extracellular domain of NTSR3 (sNTSR3) is released by shedding from several cell lines including colonic cancer cells. This soluble protein acts as an active ligand through its ability to bind, to be internalized in the human adenocarcinoma epithelial HT29 cells and to stimulate the PI3 kinase pathway. The aim of this study was to investigate cellular responses induced by sNTSR3 in HT29 cells. The cellular functions of sNTSR3 were monitored by immunofluocytochemistry, electron microscopy and quantitative PCR in order to characterize the cell shape and the expression of adhesion proteins. We evidenced that sNTSR3 significantly regulates the cellular morphology as well as the cell-cell and the cell-matrix adherens properties by decreasing the expession of several integrins and by modifying the structure of desmosomes. Altogether, these properties lead to an increase of cell detachment upon sNTSR3 treatment on HT29, HCT116 and SW620 cancer cells. Our results indicate that sNTSR3 may induce the first phase of a process which weaken HT29 epithelial properties including desmosome architecture, cell spreading, and initiation of cell separation, all events which could be responsible for cancer metastasis.
format Online
Article
Text
id pubmed-4162136
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-41621362014-09-12 Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3 Massa, Fabienne Devader, Christelle Lacas-Gervais, Sandra Béraud-Dufour, Sophie Coppola, Thierry Mazella, Jean Genes Cancer Research Paper The neurotensin (NT) receptor-3 (NTSR3), also called sortilin is a multifunctional protein localized at the intracellular and plasma membrane level. The extracellular domain of NTSR3 (sNTSR3) is released by shedding from several cell lines including colonic cancer cells. This soluble protein acts as an active ligand through its ability to bind, to be internalized in the human adenocarcinoma epithelial HT29 cells and to stimulate the PI3 kinase pathway. The aim of this study was to investigate cellular responses induced by sNTSR3 in HT29 cells. The cellular functions of sNTSR3 were monitored by immunofluocytochemistry, electron microscopy and quantitative PCR in order to characterize the cell shape and the expression of adhesion proteins. We evidenced that sNTSR3 significantly regulates the cellular morphology as well as the cell-cell and the cell-matrix adherens properties by decreasing the expession of several integrins and by modifying the structure of desmosomes. Altogether, these properties lead to an increase of cell detachment upon sNTSR3 treatment on HT29, HCT116 and SW620 cancer cells. Our results indicate that sNTSR3 may induce the first phase of a process which weaken HT29 epithelial properties including desmosome architecture, cell spreading, and initiation of cell separation, all events which could be responsible for cancer metastasis. Impact Journals LLC 2014-07 /pmc/articles/PMC4162136/ /pubmed/25221642 Text en Copyright: © 2014 Massa et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Massa, Fabienne
Devader, Christelle
Lacas-Gervais, Sandra
Béraud-Dufour, Sophie
Coppola, Thierry
Mazella, Jean
Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3
title Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3
title_full Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3
title_fullStr Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3
title_full_unstemmed Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3
title_short Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3
title_sort impairement of ht29 cancer cells cohesion by the soluble form of neurotensin receptor-3
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162136/
https://www.ncbi.nlm.nih.gov/pubmed/25221642
work_keys_str_mv AT massafabienne impairementofht29cancercellscohesionbythesolubleformofneurotensinreceptor3
AT devaderchristelle impairementofht29cancercellscohesionbythesolubleformofneurotensinreceptor3
AT lacasgervaissandra impairementofht29cancercellscohesionbythesolubleformofneurotensinreceptor3
AT berauddufoursophie impairementofht29cancercellscohesionbythesolubleformofneurotensinreceptor3
AT coppolathierry impairementofht29cancercellscohesionbythesolubleformofneurotensinreceptor3
AT mazellajean impairementofht29cancercellscohesionbythesolubleformofneurotensinreceptor3